- Biologics for the treatment of pyoderma gangrenosum in ulcerative colitis
-
Arivarasan K, Bhardwaj V, Sud S, Sachdeva S, Puri AS
- KMID: 2354955
- Intest Res.
- 2016 Oct;14(4):365-368.
- doi: 10.5217/ir.2016.14.4.365
Pyoderma gangrenosum (PG) is an uncommon extra-intestinal manifestation of inflammatory bowel disease (IBD). Despite limited published literature, biologics have caused a paradigm shift in the management of this difficult-to-treat skin... -
- CITED
-
- Close
- SHARE
-
- Close
- Rectal tuberculosis after infliximab therapy despite negative screening for latent tuberculosis in a patient with ulcerative colitis
-
Singh J, Puri AS, Sachdeva S, Sakhuja P, Arivarasan K
- KMID: 2425292
- Intest Res.
- 2016 Apr;14(2):183-186.
- doi: 10.5217/ir.2016.14.2.183
Tumor necrosis factor-α inhibitors are now considered as standard therapy for patients with severe inflammatory bowel disease who do not respond to corticosteroids, but they carry a definite risk of... -
- CITED
-
- Close
- SHARE
-
- Close
